Calvin Sternick

Stock Analyst at JP Morgan

(2.03)
# 3,049
Out of 5,156 analysts
19
Total ratings
46.15%
Success rate
7.12%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $80.57
Upside: +36.53%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $43.32
Upside: +84.67%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $34.09
Upside: -20.80%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $190.53
Upside: -4.48%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $240.59
Upside: -66.33%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $146.03
Upside: +168.44%